Use of Tocilizumab Drug Levels to Optimize Treatment in RA
Clinical trial NCT03895879 · UNKNOWN
Trial details
- NCT number
- NCT03895879
- Sponsor
- Reade Rheumatology Research Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2024-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.